ArticlePharmaceutics2026
Real-World Evolution of Prescribing Patterns and Safety Profiles of Biologic and Targeted Synthetic Therapies in Inflammatory Rheumatic Diseases: A Comparative Study Between 2018-2019 and 2023-2024.
Antonio Fabiano, Lorenza Guarnieri, Domenico Frajia, Carmela Spinoso, Massimo L'Andolina, Angelica Profiti, Damiana Scuteri, Corrado L'Andolina, Francesca Bosco, Eugenio Donato Di Paola and 2 more
Abstract read
In one paragraphArticle in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Antonio FabianoDepartment of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
Lorenza GuarnieriDepartment of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
Domenico FrajiaDepartment of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
Carmela SpinosoDepartment of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
Massimo L'AndolinaRheumatology Outpatient Clinic, ASP Vibo Valentia-Tropea Hospital, 89861 Tropea, Italy.
Angelica ProfitiRheumatology Outpatient Clinic, ASP Vibo Valentia-Tropea Hospital, 89861 Tropea, Italy.
Damiana ScuteriDepartment of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0001-5846-7058 Corrado L'AndolinaRheumatology Outpatient Clinic, ASP Vibo Valentia-Tropea Hospital, 89861 Tropea, Italy.
Francesca BoscoDepartment of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
Eugenio Donato Di PaolaDepartment of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.
Rita CitraroDepartment of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0001-6746-6751 Giovambattista De SarroDepartment of Health Sciences, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0002-7629-6579 Funding
Italian Medicines Agency D.C.A 99/2015 (AIFA 2010-2011)Italian Medicines Agency VALORE-WP2 project (AIFA 2012-2014)
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
adverse eventsbiologicsbiosimilarsinflammatory rheumatic diseasespsoriatic arthritisrheumatoid arthritis
Identifiers
PMID42654100
PMCPMC13516883
What OpenQuestion holds
Textmetadata
Read underepoch 390